Lithium Ion

Lithium Ion

SCHEMBL7702768

CN(CC(=O)[O-])C[C@H]1CCc2cc(C(F)(F)F)ccc2[C@H]1c1ccccc1.[Li+]

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 7/20 0.60
MTNR1A P48039 2/20 0.43
MTNR1B P49286 2/20 0.43
TACR1 P25103 1/20 0.42
FFAR1 O14842 1/20 0.37
SRD5A1 P18405 1/20 0.37
KDM1A O60341 2/20 0.36
PPARD Q03181 1/20 0.36
PPARA Q07869 1/20 0.36
MRGPRX4 Q96LA9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1761236 0.92 SLC6A9 (0.70) SLC6A9MTNR1AMTNR1BTACR1FFAR1
Lithium Ion SCHEMBL7702956 0.91 SLC6A9 (0.49) SLC6A9TACR1FFAR1SRD5A1
Lithium Ion SCHEMBL7703444 0.88 SLC6A9 (0.62) SLC6A9MTNR1AMTNR1BTACR1
Lithium Ion SCHEMBL7702844 0.87 SLC6A9 (0.63) SLC6A9MTNR1AMTNR1BTACR1PPARD
Lithium Ion SCHEMBL7698462 0.86 SLC6A9 (0.69) SLC6A9MTNR1AMTNR1BTACR1PPARD
Org-25935 SCHEMBL7704305 0.84 SLC6A9 (0.85) SLC6A9MTNR1AMTNR1BPPARD
Org-25935 SCHEMBL7703028 0.84 SLC6A9 (0.85) SLC6A9MTNR1AMTNR1BPPARD
SCHEMBL7698703 0.84 SLC6A9 (0.59) SLC6A9TACR1FFAR1SRD5A1PPARD
Lithium Ion SCHEMBL7700187 0.83 SLC6A9 (0.70) SLC6A9MTNR1AMTNR1BPPARD
Lithium Ion SCHEMBL7704525 0.82 SLC6A9 (0.69) SLC6A9MTNR1AMTNR1BPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100769-B1 AMINOMETHYLCARBOXYLIC ACID DERIVATIVES AKZO NOBEL NV (NL) 2002-12-04 EP disclosed
US-6410592-B1 THERAPY FOR CENTRAL NERVOUS SYSTEM DISORDERS, PSYCHOLOGICAL DISORDERS AKZO NOBEL N.V. (NL) 2002-06-25 US disclosed